Business Wire

FL-H.I.G.-CAPITAL

Share
H.I.G. Capital Announces Sale of ICG Group to SPIE Group

H.I.G. Capital (“H.I.G.“), a leading global alternative investment firm with $60 billion of capital under management, is pleased to announce that it has signed a definitive agreement to sell its German portfolio company ICG Group (the “company” or “ICG”) to SPIE Group, a European leader in multi-technical services in the areas of energy and communications, listed on the Paris stock exchange (Ticker: SPIE). ICG’s management will remain in place and continue to drive the company’s future development. The transaction is subject to clearance by antitrust authorities.

ICG Group was initially launched in 2021, with H.I.G.’s platform investment in Infratech, which builds complex FTTx networks on behalf of public and private German network operators. ICG subsequently acquired comcross, one of Germany’s leading service providers for mobile telecommunication infrastructure. The mobile communication segment was further developed through ICG’s bolt-on investments in telecommunication solutions providers Schwan and TripleA as well as telecommunication network planner DPE. Today, ICG has more than 700 employees in 16 locations throughout Germany, mainly, as well as in the Netherlands, and Croatia. The company has built more than 15,000 mobile communications sites, deployed more than 15,000 kilometers of fiber-optic lines, and connected more than 100,000 households to the fiber-optic network ("homes passed"). ICG’s revenue quadrupled during H.I.G.’s ownership.

Holger Kleingarn, Managing Director at H.I.G., commented, “We are very pleased to have assembled the ICG Group, uniquely offering customers a single point of contact for the entire value chain of digital infrastructure services. Our engagement in ICG underlines H.I.G.’s expertise in identifying strong platforms in key future industries and sustainably expanding them via organic growth and selected acquisitions. We have established ICG Group as the leading enabler of next-generation infrastructures and turnkey network solutions in Germany and beyond. We thank the management team of Vladimir Suznjevic and Gregor Klaßen for the highly trustful and successful partnership and wish them continued success for the next phase of ICG Group’s development.”

Vladimir Suznjevic, Managing Director of ICG Group and responsible for the mobile communication business, commented, "Technologies such as Industry 4.0, autonomous driving, and artificial intelligence require a significant expansion of digital infrastructure in Germany and Europe. In addition, while the 5G mobile communication standard is currently being rolled out, 6G is already in development. In order to best drive the European digitization, a technical integration of mobile communications and fiber-optic infrastructure is key. At ICG, with the support of H.I.G. and now SPIE, we are ideally positioned to continue meeting this requirement for the benefit of our trusted customers."

Gregor Klaßen, Managing Director of Infratech and responsible for its fiber-optic business, commented, "Germany will catch up to the industrialized countries in fiber optic roll-out over the next decade, resulting in an ongoing high demand for experienced and reliable service providers in the areas of fiber optic planning, civil engineering, and installation. We have trusted relationships with our public-sector and corporate clients, allowing us to implement large turnkey networks for them. We thank H.I.G. for the strong support over the past years. We are looking forward to continue ICG’s success story as part of SPIE Group."

About ICG Group

ICG Group, headquartered in Leonberg (Germany), combines the competencies of the leading communication infrastructure service providers: Infratech, comcross, Schwan, TripleA Networks, and DPE. The Group covers the entire value chain from planning and construction to installation and maintenance of infrastructures for fiber-optic, mobile communications, and electricity networks. All units of the Group are characterized by a strong position in their respective segments and long-standing customer relationships. The ICG Group has more than 700 employees in 16 locations throughout Germany, mainly, as well as in the Netherlands, and Croatia. For more information, please visit icg-gruppe.de.

About H.I.G. Capital

H.I.G. Capital is a leading global alternative investment firm with $60 billion of capital under management.* Based in Miami, and with offices in Atlanta, Boston, Chicago, Dallas, Los Angeles, New York, and San Francisco in the United States, as well as international affiliate offices in Hamburg, London, Luxembourg, Madrid, Milan, Paris, Bogotá, Rio de Janeiro, São Paulo, and Dubai, H.I.G. specializes in providing both debt and equity capital to middle market companies, utilizing a flexible and operationally focused/value-added approach:

  • H.I.G.’s equity funds invest in management buyouts, recapitalizations and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.
  • H.I.G.’s debt funds invest in senior, unitranche and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets. H.I.G. also manages a publicly traded BDC, WhiteHorse Finance.
  • H.I.G.’s real estate funds invest in value-added properties, which can benefit from improved asset management practices.
  • H.I.G. Infrastructure focuses on making value-add and core plus investments in the infrastructure sector.

Since its founding in 1993, H.I.G. has invested in and managed more than 400 companies worldwide. The Firm's current portfolio includes more than 100 companies with combined sales in excess of $53 billion. For more information, please refer to the H.I.G. website at hig.com.

*Based on total capital raised by H.I.G. Capital and its affiliates.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240308259866/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye